Switching from tenofovir and nucleoside analogue therapy to tenofovir monotherapy in virologically suppressed chronic hepatitis B patients with antiviral resistance

Publisher： John Wiley & Sons Inc

E-ISSN： 1096-9071|90|3|497-502

ISSN： 0146-6615

Source： JOURNAL OF MEDICAL VIROLOGY, Vol.90, Iss.3, 2018-03, pp. : 497-502

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tenofovir‐based rescue therapy in chronic hepatitis B patients with suboptimal responses to adefovir with prior lamivudine resistance

By  

JOURNAL OF MEDICAL VIROLOGY, Vol. 87, Iss. 9, 2015-09 ,pp. : 1532-1538

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tenofovir rescue regimen following prior suboptimal response to entecavir and adefovir combination therapy in chronic hepatitis B patients exposed to multiple treatment failures

By  

JOURNAL OF MEDICAL VIROLOGY, Vol. 87, Iss. 6, 2015-06 ,pp. : 1013-1021

John Wiley & Sons Inc

Access to resources Recommend Favorite

Is zidovudine first‐line therapy virologically comparable to tenofovir in resource‐limited settings?

By  

TROPICAL MEDICINE & INTERNATIONAL HEALTH, Vol. 20, Iss. 7, 2015-07 ,pp. : 914-918

John Wiley & Sons Inc

Access to resources Recommend Favorite

Switching from zidovudine/lamivudine to tenofovir/emtricitabine improves fat distribution as measured by fat mass ratio

By  

HIV MEDICINE, Vol. 16, Iss. 6, 2015-07 ,pp. : 370-374

John Wiley & Sons Inc

Access to resources Recommend Favorite

CD4 count monitoring seldom contributes to clinical‐decision making

By  

HIV MEDICINE, Vol. 16, Iss. 3, 2015-03 ,pp. : 196-200

John Wiley & Sons Inc

Access to resources Recommend Favorite